Salvage haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is considered in patients with severe
The AAMDSIF 2018 Scientific Symposium Patient Summary is now available in print format.
Containing 30 lay language summaries of presentations from a panel of international experts,
Don’t give up hope, because the chances of finding a cure for acute myeloid leukemia (AML) are improving every day.
Attenuated doses of hypomethylating agents (HMA) early in treatment could improve outcomes among transfusion independent patients with lower-risk myelodysplastic syndromes (MDS), according to findings that will be presented at the American Society of Clinical Oncology 2018 Annual Meeting in Chicago, Illinois.1
Handy list to keep for potential evacuations.
No abstract available